Serum angiopoietin-2 as a clinical marker for lung cancer. - Wikidata - awgldk - TriplyDB

Serum angiopoietin-2 as a clinical marker for lung cancer.

Serum angiopoietin-2 as a clinical marker for lung cancer.

http://www.wikidata.org/entity/Q53570593

about

A novel angiopoietin-2 selective fully human antibody with potent anti-tumoral and anti-angiogenic efficacy and superior side effect profile compared to Pan-Angiopoietin-1/-2 inhibitors.Angiogenesis-related biomarkers in patients with alcoholic liver disease: their association with liver disease complications and outcome.Angiopoietin-2: development of inhibitors for cancer therapy.Identification of serum angiopoietin-2 as a biomarker for clinical outcome of colorectal cancer patients treated with bevacizumab-containing therapy Association of angiopoietin-2, C-reactive protein and markers of obesity and insulin resistance with survival outcome in colorectal cancer Circulating Ang-2 mRNA expression levels: looking ahead to a new prognostic factor for NSCLC [corrected]Serum vascular endothelial growth factor and angiopoietin-2 are associated with the severity of systemic inflammation rather than the presence of hemoptysis in patients with inflammatory lung disease.Why targeted therapy hasn't worked in advanced cancer.Prognostic value of angiopoietin-2 in non-small cell lung cancer patients: a meta-analysis.Evaluation of serum and pleural levels of angiopoietin-1 and angiopoietin-2 in children with transudative and exudative pleural effusions.Endothelial cell-derived angiopoietin-2 is a therapeutic target in treatment-naive and bevacizumab-resistant glioblastoma.Serum biomarkers of papillary thyroid cancer Evaluation of Angiopoietin-2 as a biomarker in gastric cancer: results from the randomised phase III AVAGAST trial.Plasma angiopoietin-2 is persistently elevated after non-small cell lung cancer surgery and stimulates angiogenesis in vitro.Bench-to-bedside review: Angiopoietin signalling in critical illness - a future target?Blood vessel maturation, vascular phenotype and angiogenic potential in malignant melanoma: one step forward for overcoming anti-angiogenic drug resistance?Targeting angiopoietin-2 signaling in cancer therapy.Targeting the Angiopoietin-2/Tie-2 axis in conjunction with VEGF signal interference.Combined Ang-2 and VEGF serum levels: holding hands as a new integral biomarker in non-small-cell lung cancers.Statins, 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, potentiate the anti-angiogenic effects of bevacizumab by suppressing angiopoietin2, BiP, and Hsp90α in human colorectal cancer Angiopoietin pathway gene expression associated with poor breast cancer survival.Anti-angiogenesis by lentivirus-mediated small interfering RNA silencing of angiopoietin-2 gene in pancreatic carcinoma.Prognostic significance of TIE2-expressing monocytes in hilar cholangiocarcinoma.The role of serum angiopoietin-2 levels in progression and prognosis of lung cancer: A meta-analysis.Time-dependent changes of plasma concentrations of angiopoietins, vascular endothelial growth factor, and soluble forms of their receptors in nonsmall cell lung cancer patients following surgical resection.Circulating angiopoietin-2, its soluble receptor Tie-2, and mortality in the general population.Angiopoietin 2 levels in serum and bronchial lavage fluids and their relationship with cancer stages in lung cancer patients.Serum levels of angiopoietin-1, angiopoietin-2, and their receptor tie-2 in patients with nonsmall cell lung cancer during chemotherapy.MicroRNA-542-3p inhibits tumour angiogenesis by targeting angiopoietin-2.Angiopoietin-2 mediates blood-brain barrier impairment and colonization of triple-negative breast cancer cells in brain.Bloch surface wave enhanced biosensor for the direct detection of Angiopoietin-2 tumor biomarker in human plasma.Prognostic value of pro-inflammatory cytokine and pro-angiogenesis factor in differentiating malignant from benign exudative effusion.VEGF-D and A Preoperative Serum Levels Predict Nodal and Distant Metastases in Differentiated Thyroid Cancer Patients.Vascular endothelial growth factors and angiopoietins in presentations and prognosis of papillary thyroid carcinoma.[The influence of inhibiting angiopoietin-2 on the biological characteristics of bronchogenic adenocarcinoma].Angiogenic miRNAs, the angiopoietin axis and related TIE2-expressing monocytes affect outcomes in cholangiocarcinoma

P2860

Q31110832-4C55BF0C-29D7-46A2-AE88-8C55D8DB77F8 Q33736254-AD925975-B6C8-4DD3-89DE-BD10B5797E43 Q33839423-22721FA4-F873-40D3-AF8E-ACA67733C03B Q34344165-12D77BFF-3A36-4824-9560-1A8C3D148478 Q34577576-B4CC144B-6E7A-456D-9F65-2EED502363CA Q35108561-CAA6F557-0016-4383-BE2A-90E0785A1CF0 Q35767455-3FB04AC3-1B14-4E6F-87A8-6D5B7D5A8DEF Q36014536-A737C686-CD9F-4FFB-98BA-D941675066B4 Q36121903-25BEFE89-595D-41B3-B3E9-DDBCD034447A Q36244857-BC456202-0084-4F05-B69E-18763B93B8B5 Q36477818-D7B15F04-B533-426C-810D-190B293CC0D7 Q36834893-324DBEA8-B06A-45FC-B17A-88C7F86988E6 Q37174690-038FF709-616D-46EB-AF60-A8C941FF3D89 Q37175995-A36EC866-C346-4004-8D33-C84E64EA6824 Q37478709-C88D6565-A2F0-42AE-B923-4E04778D1BC1 Q37846342-31947D4B-E507-4969-BD6B-9EB2BEA1CF52 Q38101997-928A44D5-738F-4B18-81ED-4A0B1F438A9D Q38259982-A076A86D-CCC2-4496-92F0-81A68B6A7AA7 Q38943409-67A517EB-2C55-4CAD-9A70-1DE3D071DD6F Q38982959-49978E03-88D8-4250-A598-27CFDFC0B05E Q39034717-694B82C6-00A8-4AF7-AAF6-E9DE6537BA18 Q39512686-950CD1C8-9C22-41D5-8AAE-A13F030C7698 Q39824985-EFE889D4-4FBF-4C63-94C2-533A175F525F Q42111598-CDCB373F-2B59-48F2-807A-6B4E0DACDD2E Q42548913-97C0D891-6B6F-441C-B1F0-998EE2FE1C41 Q46211892-23384375-D0E1-4015-9B12-C5A681C0EB3B Q50050101-77550DA6-E51F-4269-B553-152DB5F40489 Q51739600-6EDD16A3-BE2B-4012-81EA-7D72577277BC Q51760093-A6B04573-1BC7-4C1E-9884-19214E1F2450 Q52646854-35D0D75E-7CA4-4951-8EB6-34DD45EEE408 Q52649539-2F7D29A1-0DDD-430A-9823-8C539054FB27 Q53804643-6BDB26AF-C8D9-4795-8818-04FEB5541F32 Q54291391-87EA9FC4-B03D-40FF-B4C4-46B566811E5B Q54604716-7E694953-7693-4036-9660-0E411CA17B9C Q55444655-F93A77E1-1B6B-4928-8636-B37DF2A7B431 Q56956744-C19C688C-49AE-4739-A40F-50F12530AB92

P2860

Serum angiopoietin-2 as a clinical marker for lung cancer.

http://www.wikidata.org/entity/Q53570593

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh-hant

name

Serum angiopoietin-2 as a clinical marker for lung cancer.

@en

Serum angiopoietin-2 as a clinical marker for lung cancer.

@nl

type

label

Serum angiopoietin-2 as a clinical marker for lung cancer.

@en

Serum angiopoietin-2 as a clinical marker for lung cancer.

@nl

prefLabel

Serum angiopoietin-2 as a clinical marker for lung cancer.

@en

Serum angiopoietin-2 as a clinical marker for lung cancer.

@nl

P1433

Q53570593-8C28B1E2-F7AF-4876-B7F8-C598F78E4778

P1476

Q53570593-294DD6AA-BF3B-4E74-9C96-9FC9DF5EA92C

P2093

Q53570593-0E27CD3D-E6EB-4263-9EB5-A3B45A45D763

Q53570593-2D505CA4-4206-4DF1-A7B2-5CF3460B64A8

Q53570593-74454D10-0D20-40DD-911C-3532CFF1CDB9

Q53570593-AA04AB40-7A8D-404E-B00A-6B69613AAA13

Q53570593-AB083821-5C13-4114-A0F8-F745551B3DD8

Q53570593-DA458D3E-B695-4EDF-B69B-3F04C70654A2

Q53570593-E49FF29F-C8DB-438F-83E0-826F7CACDFCC

P304

Q53570593-5C2621FA-3B7B-4672-9B5B-071A0D26D7C8

P31

Q53570593-4D406C2C-3BC0-473F-BC2B-6A4BACD76D66

P356

Q53570593-6C895A38-0CAA-4FC7-A7D4-FF8DA15906E0

P407

Q53570593-5D3A9157-61F2-47C6-9FD7-1D49B2F3693D

P433

Q53570593-67E734C2-FA79-4F96-B6C7-8C2857DECEC4

P478

Q53570593-0778DE50-8D45-4027-8693-94677AB70260

P50

Q53570593-B24AFA48-CFBA-4B39-B711-3C221A450101

P577

Q53570593-B0F5BF8A-50D9-484B-8010-AA75963BFA48

P698

Q53570593-D910FC94-02C0-4675-AFD1-51BA2A4D52DF

P356

P1433

P1476

Serum angiopoietin-2 as a clinical marker for lung cancer.

@en

P2093

Hyoung No Lee

http://www.w3.org/2001/XMLSchema#string

Joo Hun Park

http://www.w3.org/2001/XMLSchema#string

Keu Sung Lee

http://www.w3.org/2001/XMLSchema#string

Kwang Joo Park

http://www.w3.org/2001/XMLSchema#string

Seung Soo Sheen

http://www.w3.org/2001/XMLSchema#string

Yoon Jung Oh

http://www.w3.org/2001/XMLSchema#string

Young Sun Kim

http://www.w3.org/2001/XMLSchema#string

P304

200-206

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1378/CHEST.06-2915

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

132

http://www.w3.org/2001/XMLSchema#string

P50

Sung Chul Hwang

P577

2007-05-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17505039

http://www.w3.org/2001/XMLSchema#string